Borviz 2.5 Injection

Get a Price/Quote

Borviz 2.5 Injection Specification

Salt Composition
Bortezomib

Pacakaging (Quantity Per Box)
1 vial per box

Origin of Medicine
Synthetic

Drug Type
Injection

Ingredients
Boronic Acid Mannitol Sodium Hydroxide

Physical Form
Liquid

Function
Used in the treatment of certain cancers (e.g. multiple myeloma mantle cell lymphoma)

Recommended For
Patients diagnosed with applicable cancers as prescribed

Dosage
2.5 mg per administration

Dosage Guidelines
Administered under medical supervision intravenously or subcutaneously as directed by the oncologist

Suitable For
Adults

Quantity
Single-dose vial (2.5 mg strength)

Storage Instructions
Store at temperatures below 25C protect from light and moisture

About Borviz 2.5 Injection

Borviz 2.5 Injection is a potent medication specifically designed for the treatment of certain types of cancers such as multiple myeloma and mantle cell lymphoma. This injection contains Boronic Acid, Mannitol, and Sodium Hydroxide as ingredients, with Bortezomib as the active salt composition. Available in a convenient single-dose vial with a strength of 2.5 mg, this liquid formulation is administered intravenously or subcutaneously under medical supervision. Suitable for adult patients diagnosed with applicable cancers, it is recommended to store this injection below 25C, protected from light and moisture.

FAQs of Borviz 2.5 Injection:

Q: Who can use Borviz 2.5 Injection?

A: Borviz 2.5 Injection is suitable for adults diagnosed with certain cancers as prescribed by their healthcare provider.

Q: How should Borviz 2.5 Injection be stored?

A: Borviz 2.5 Injection should be stored at temperatures below 25C, shielded from light and moisture.

Q: What is the recommended dosage of Borviz 2.5 Injection?

A: The recommended dosage of Borviz 2.5 Injection is 2.5 mg per administration, to be given intravenously or subcutaneously as directed by the oncologist.